The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcome of patients (Pts) with metastatic renal cell carcinoma (mRCC) progressing on front-line immune-oncology based combination (IO-COMBO) regimens.
 
Pedro C. Barata
No Relationships to Disclose
 
Alfonso Gomez de Liano
No Relationships to Disclose
 
Prateek Mendiratta
No Relationships to Disclose
 
Valerie Crolley
No Relationships to Disclose
 
Bernadett Szabados
No Relationships to Disclose
 
Laura S. Wood
Consulting or Advisory Role - Exelixis; Merck
Speakers' Bureau - Bristol-Myers Squibb; Novartis; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Exelixis; Novartis; Pfizer
 
Beth Zanick
No Relationships to Disclose
 
Kimberly D Allman
Honoraria - Exelis; Pfizer; Sanofi
Consulting or Advisory Role - Exelis
Speakers' Bureau - Exelis; Pfizer; Sanofi
 
Allison Janine Tyler
Honoraria - AstraZeneca; Bayer
Consulting or Advisory Role - AstraZeneca; Bayer
Speakers' Bureau - AstraZeneca; Bayer
Travel, Accommodations, Expenses - AstraZeneca; Bayer
 
Allison Martin
No Relationships to Disclose
 
Timothy D. Gilligan
Travel, Accommodations, Expenses - WellPoint
 
Petros Grivas
Consulting or Advisory Role - AstraZeneca; Bayer; Biocept; Bristol-Myers Squibb; Clovis Oncology; Dendreon; EMD Serono; Exelixis; Genentech; Merck
Speakers' Bureau - Bristol-Myers Squibb; Genentech
Research Funding - AstraZeneca (Inst); Bayer (Inst); Genentech/Roche (Inst); Merck (Inst); Mirati Therapeutics (Inst); Oncogenex (Inst); Pfizer (Inst)
 
Moshe Chaim Ornstein
No Relationships to Disclose
 
Jorge A. Garcia
Consulting or Advisory Role - Bayer; Eisai; Exelixis; Genentech/Roche; Medivation; Pfizer; Sanofi
Speakers' Bureau - Bayer; Genentech/Roche; Medivation/Astellas; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Lilly (Inst); Orion (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bayer; Eisai; Exelixis; Genentech/Roche; Medivation/Astellas; Pfizer; Sanofi
 
Thomas Powles
Honoraria - Bristol-Myers Squibb; MERCK; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Merck; Novartis
Research Funding - AstraZeneca/MedImmune; Roche/Genentech
Other Relationship - Bristol-Myers Squibb; Ipsen
 
Brian I. Rini
Consulting or Advisory Role - Corvus Pharmaceuticals; Merck; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Pfizer